SalaryGuide
SalariesCompaniesJobs
AboutPricingBlogFor Employers

Marketing jobs

4 marketing jobs

Demant logo
1 day ago

Director, Consumer Marketing

Demant

Somerset, NJ (Hybrid)Full time$170K/yr – $189K/yr
Demant logo
5 months ago

Marketing Specailist

Demant

Arlington Heights, IL (Hybrid)$65K/yr – $80K/yr
Demant logo
6 months ago

Digital Marketing Manager

Demant

New Jersey, USA (Hybrid)Unavailable
Demant logo
6 months ago

Marketing Specialist, New Markets and Acquisitions

Demant

New Jersey, USA (Hybrid)Unavailable

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

4 jobs
Demant logo

Director, Consumer Marketing

Demant

Somerset, NJ (Hybrid)

$170K/yr - $189K/yrIn-houseFull-timeDirector/executive10+ years exp.
1 day ago
Demant logo

Marketing Specailist

Demant

Arlington Heights, IL (Hybrid)

$65K/yr - $80K/yrIn-houseMid level3+ years exp.
5 months ago
Demant logo

Digital Marketing Manager

Demant

New Jersey, USA (Hybrid)

In-houseUnavailableSenior level5+ years exp.
6 months ago
Demant logo

Marketing Specialist, New Markets and Acquisitions

Demant

New Jersey, USA (Hybrid)

In-houseUnavailableMid level4+ years exp.
6 months ago
Demant logo
Demant

Director, Consumer Marketing

Somerset, NJ (Hybrid)

$170K/yr – $189K/yrDirector/Executive10+ years expFull time

Posted 1 day ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Owns and executes consumer marketing strategy and demand programs, leads a cross‑functional team, and partners with Product, Sales, and Customer Experience to drive growth.

Job Description

Responsibilities

  • Develop and execute comprehensive consumer marketing strategies aligned with business objectives and growth priorities.
  • Assist practices in driving awareness, consideration, and demand for the company's products and solutions among patients, caregivers, and consumers.
  • Create scalable B2B2C marketing programs that support consumer engagement and partner growth.
  • Develop annual marketing plans, budgets, and performance objectives.
  • Design and implement integrated marketing campaigns across digital, social, content, email, and traditional marketing channels.
  • Build consumer demand-generation programs that drive qualified leads to providers, clinics, and partners.
  • Create consumer-focused marketing assets, campaigns, and toolkits that can be leveraged across partner networks.
  • Collaborate with regional and local stakeholders to adapt campaigns for market-specific needs.
  • Ensure alignment between consumer marketing strategies and commercial objectives.
  • Partner closely with Product Management, Sales, and Customer Experience teams.

Requirements

  • Bachelor's degree in Marketing, Business Administration, Communications, or a related field required.
  • MBA a plus.

Preferred

  • MBA a plus.

Benefits

  • Medical, dental, prescription, and vision benefits
  • 24/7 virtual medical care
  • Employee Assistance Program for you and your family
  • 401(k) with company match
  • Company-paid life insurance
  • Supplemental insurance for yourself, your spouse/partner, and your children
  • Short-term and long-term disability insurance
  • Pre-tax Health Savings Account and Flexible Spending Accounts for Health Care or Dependent Care
  • Pet Insurance
  • Commuter accounts
Demant logo

Demant

3.8 Glassdoor

Demant is a world-leading hearing healthcare group built on a heritage of care, health and innovation since 1904. The Group offers solutions and services to help people connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and gathering know-how to help improve people’s hearing and health. In every aspect, from providing hearing care to delivering hearing aids and diagnostic equipment and services to hearing care professionals and users all over the world, Demant is active and engaged.The Demant Group operates in a global market with subsidiaries in more than 30 countries, employs more than 22,000 employees and generates annual revenue of more than DKK 22 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health.Listed on Nasdaq Copenhagen stock exchange as a blue chip stock, Demant is the parent company behind world-renowned and commercially successful brands as Oticon, Bernafon, Sonic, Philips Hearing Solutions, Audika, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx and Audioscan. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.If you want to know how we process your personal data on social media platforms, visit this site: https://www.demant.com/privacy-notice#some

Founded in 1904
Copenhagen, Capital Region of Denmark, DNK
5.1K employees (406 in marketing)
www.demant.com
80% recommend to a friend
94% CEO approval

Salaries

Posted range

$170K/yr – $189K/yr

Taken straight from the job posting.

See all Demant salaries

Marketing Team

Marketing Team Size
307 (6% of company)
Median Tenure
3.5 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$169.4M
Last Raise
$54.6M
Post IPO Debt, 3 years ago

Funding History

  • Mar 2023
    Post IPO Debt • $54.6M
  • Nov 2022
    Post IPO Debt • $114.8M

Traffic Signals

Monthly Visitors
164.5K
Traffic Source Mix
Search
31.6%
Direct
45.2%
Referral
13.8%
Social
8%
Paid
1.2%

Headcount Trend

Current headcount: ~5.1K

Recent News

Will Demant A S (Common Stock) (WDH) stock benefit from mergers - Portfolio Return Summary & Safe Capital Growth Stock Tips
Nov 2, 2025 • newser.com
Will Demant A S (Common Stock) (WDH) stock benefit from mergers - 2025 AllTime Highs & High Conviction Trade Alerts
Oct 31, 2025 • newser.com
Why Demant A S (WDH1) stock could rally strongly - Quarterly Investment Review & Daily Growth Stock Tips
Oct 30, 2025 • newser.com
Demant boss hopes to get more people into hearing treatment with new discreet AI product
Oct 24, 2025 • medwatch.com
Analyst on the price of Demant sale: Not that impressive
Oct 22, 2025 • medwatch.com
Demant To Sell Oticon Medical To Impilo For Up To DKK 600 Mln
Oct 22, 2025 • Nasdaq
Demant's Oticon Launches New AI-Powered Hearing Aid
Oct 22, 2025 • MarketScreener
Demant sells BAHS business to Impilo for up to DKK600m
Oct 22, 2025 • Investing.com India
Demant Sells Oticon Medical to Impilo for Up to 600 Million Danish Kroner
Oct 22, 2025 • MarketScreener
Impilo to buy Oticon Medical from Demant
Oct 22, 2025 • pehub.com
Demant A/S: Demant to sell Oticon Medical to Impilo
Oct 21, 2025 • MarketScreener
Demant A/S (OTCMKTS:WILYY) Shares Gap Up - Time to Buy?
Oct 21, 2025 • MarketBeat
William Demant Foundation Raises Stake to 20.3 Percent in Invisio
Oct 16, 2025 • MarketScreener
Demant A/S: Quarterly Trading Report 2025 Q3
Oct 3, 2025 • TradingView
Lineage Nabs $12M Demant Partnership
Sep 8, 2025 • San Diego Business Journal
Earnings call transcript: Demant Q2 2025 revenue miss leads to stock dip
Sep 3, 2025 • Investing.com
Demant-owner to develop new cell therapy for treating hearing loss with US biotech company
Aug 28, 2025 • medwatch.com
Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss
Aug 26, 2025 • Business Wire
J.P. Morgan Maintains DEMANT A/S(WILLF.US) With Buy Rating, Raises Target Price to $45.43
Aug 15, 2025 • 富途牛牛
Demant CEO confident about KIND acquisition integration: “They are used to our products"
Aug 14, 2025 • medwatch.com
Demant sales hit by Sonova comeback at Costco in second quarter
Aug 13, 2025 • medwatch.com
Citi Maintains DEMANT A/S(WILLF.US) With Buy Rating, Announces Target Price $52.57
Aug 12, 2025 • 富途牛牛
Hearing Aids Market worth US$14.42 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
Aug 12, 2025 • PR Newswire
Hearing Aids Market worth US$14.42 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
Aug 12, 2025 • PR Newswire UK
Bernstein Maintains DEMANT A/S(WILLF.US) With Buy Rating, Raises Target Price to $52.67
Jul 17, 2025 • 富途牛牛
Deutsche Bank Maintains DEMANT A/S(WILLF.US) With Hold Rating, Raises Target Price to $43.35
Jul 13, 2025 • 富途牛牛
Barclays upgrades Demant stock rating on achievable guidance
Jun 20, 2025 • Investing.com
Latham & Watkins Advises Demant on Agreement to Acquire KIND Group
Jun 13, 2025 • Latham & Watkins LLP
Demant still eyeing acquisitions in 2025
Jun 12, 2025 • medwatch.com
Demant CEO: KIND acquisition will lead to guidance upgrade
Jun 11, 2025 • medwatch.com
Demant expands in German through 700 million euro Kind deal
Jun 11, 2025 • Reuters
Demant acquires German hearing aid retailer KIND Group
Jun 11, 2025 • medwatch.com
Germany: Demant expanding hearing care footprint with acquisition of Kind Group
Jun 11, 2025 • Investors in Healthcare
Denmark's Demant acquires German hearing aid firm KIND for €700m
Jun 11, 2025 • Yahoo Finance
Demant surpasses Novo Nordisk on list of Europe's best employers
May 21, 2025 • medwatch.com
Strategic mistake in the US makes matters worse for Demant: "Sometimes you misjudge the situation a bit"
May 7, 2025 • medwatch.com
Demant AS N (WDH.F) Q1 FY2025 earnings call transcript
May 7, 2025 • Yahoo Finance
Newborn Screening Market Analysis (2024-2035): A Comprehensive Insight into Future Trends, Innovations, and Opportunities
Apr 11, 2025 • PharmiWeb
Demant and WSA lose market share in key US sales channel
Mar 17, 2025 • medwatch.com
Hearing Aids Market Is Booming Worldwide 2025-2032: Sonic, Zounds Hearing, Audicus, GN Hearing, WS Audiology A/S, Oticon
Mar 17, 2025 • EIN Presswire
Neonatal Hearing Screening Device Market to Reach US$ 68.5 Million by 2034, Growing at a 4.90% CAGR
Mar 12, 2025 • EIN Presswire
Hearing Aids Market Size, Share, Trends, Demand Growth An...
Feb 12, 2025 • PharmiWeb.com
Demant ready with new AI hearing aids in Q1
Feb 5, 2025 • medwatch.com
Demant CEO on strategic decision in the US: "It was a mistake"
Feb 5, 2025 • medwatch.com
Watkins Advises Demant on Acquisition of OHRWERK Group
Feb 3, 2025 • Latham & Watkins LLP
Demant's production not immediately affected by tariff wall against Mexico
Feb 3, 2025 • medwatch.com
Germany: Nord Holding sells Ohrwerk Group stake to Demant
Jan 23, 2025 • Investors in Healthcare
Demant snaps VA market share from Sonova
Jan 17, 2025 • medwatch.com
Morgan Stanley raises price targets of Amplifon and Demant
Jan 7, 2025 • medwatch.com
Demant receives EUR 120m loan for hearing aid development
Dec 18, 2024 • medwatch.com
Equality lawyers criticize Demant for top appointment: "You can't pull that trick"
Dec 2, 2024 • medwatch.com
BNP Paribas Exane lowers target price for Demant to DKK 245 (250), reiterates underperform - BN
Nov 6, 2024 • MarketScreener
Demant CEO: We aren't shying away from tough market competition
Nov 5, 2024 • medwatch.com
Demant A/S: Capital Markets Day 2024 - Sharpened focus on Hearing Healthcare | Demant A/S
Mar 24, 2024 • Via Ritzau
Global Hearing Aids Market Outlook 2024-2029: A $8.55 Billion Market in 2029, Registering CAGR of 4.25% - Sonova ...
Feb 16, 2024 • GlobeNewswire
Demant A/S: Results for 2023 and outlook for 2024 | Demant A/S
Feb 5, 2024 • Via Ritzau
Demant A/S reports 1H results
Aug 16, 2023 • SeekingAlpha
How Much Of Demant A/S (CPH:DEMANT) Do Institutions Own?
Sep 30, 2019 • Yahoo Finance
Philips to private-label Demant hearing aids
Apr 12, 2019 • Mass Device
European markets close lower; HSBC shares slide 4%
Jan 1, 1970 • CNBC
Amplifon shares hit record on $617 million Gaes Group deal
Jan 1, 1970 • Reuters UK
Sivantos owner EQT forges US$8 billion hearing aid deal
Jan 1, 1970 • Channel NewsAsia

Links

www.demant.comLinkedInCrunchbase